It is important to note that in LIHC, as well as other cancers, P53-mediated processes can also be functionally inactivated even when the P53 gene itself is not mutated through alternative mechanisms including mutation of MDM proteins, dysregulation of microRNAs, as well as action of the hepatitis viruses (41, 42). The gene discussed is TP53; the disease is cancer.